Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
about
CYP3A4 and CYP3A5 genotyping by PyrosequencingGenetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic reviewReview of studies on metabolic genes and cancer in populations of African descent.Minireview: the molecular and genomic basis for prostate cancer health disparitiesThe PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patientsAssociation of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.Genomewide scan for prostate cancer-aggressiveness loci.Decision tree-based modeling of androgen pathway genes and prostate cancer riskSipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments.New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study.Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.SNPs in cancer research and treatment.Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest ChinaEthnicity and Prostate Cancer in Southern Nigeria: A Preliminary Report.Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patientsGenetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF-1, and IGFBP-3 and prostate cancer risk in African-American men: the Flint Men's Health Study.Molecular mechanisms involving prostate cancer racial disparity.Pharmacogenomics of CYP3A: considerations for HIV treatment.Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.The role of miR-24 as a race related genetic factor in prostate cancer.CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH databaseMolecular mechanisms involving prostate cancer racial disparity.Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.
P2860
Q24810187-7DAB83FF-0AAC-45CE-B5D2-FE35E8398BC8Q26823434-96F58BDC-61C2-44E3-960D-E59F508A4959Q30494890-4A953C55-2D9E-4DCC-846E-8159DEE24383Q33633160-56B30F31-316D-4421-AB35-69B04BC9B901Q33749037-F7EEAD24-9673-4D24-AECC-BA3C017B0A69Q33937239-80B48F22-90BA-4925-95A9-669DE99EF17FQ33970160-646C0B1D-DFC3-4B63-94C5-BCA25BCFA1B2Q34141936-510B77B4-E4F6-409A-9150-B2DA432C20B5Q35036697-D50CC9D2-2C00-4DCD-96DE-993950C174DEQ35128716-F02F7704-84E4-4527-81DA-B87A519EA0CAQ35588955-2380CBDF-B31C-4A21-8E54-3B63CA184290Q35661209-3EFF37A1-7617-44CE-B616-23EC86C0B5FDQ35670196-B26F0090-6B3A-4217-A8F6-BFA0B0067D41Q35919286-96262CA5-4A03-4E6B-BA77-3FCAEDFA50AEQ36050309-76B5E305-E7DC-47A0-AC22-46A34675B8A9Q36293101-A5FA16C8-E15E-4527-A391-B65776D89CEEQ36365599-D594F69D-4198-4007-B0D1-811C4D67817AQ36758880-14AAB0C3-EAB8-4445-9957-BBC799BEC21EQ36951975-B0024845-42CE-4299-8D40-6674AF762D3AQ37267225-24214BE4-9F61-4F6F-B1B4-4087B1CB2398Q37418937-F1A23D4A-4494-4D4A-A559-897B5B2CB48EQ37419542-4FF0F903-16F0-4A33-8BAC-9DE6B2E41B65Q37436048-57723EC1-0AD6-445E-82B6-A6FC4D298C99Q37725482-70180F94-D415-4445-B01C-9B40BD4D2211Q38308526-C0A07B2F-71D5-43EF-8418-A90637476A8FQ38557382-442A8971-8DC4-41B2-8988-61D91AA61282Q45327318-252B1A3F-AFB0-4CD1-BEA9-ABBB2F7843ECQ46726161-6E075E5F-9A01-426D-8C0C-BFE123E63783Q50179674-8CFB5246-8711-452F-91A7-F5240015EB8D
P2860
Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Association between a CYP3A4 g ...... ican prostate cancer patients.
@en
type
label
Association between a CYP3A4 g ...... ican prostate cancer patients.
@en
prefLabel
Association between a CYP3A4 g ...... ican prostate cancer patients.
@en
P2093
P1476
Association between a CYP3A4 g ...... rican prostate cancer patients
@en
P2093
P A Kupelian
T L Williams
P304
P577
1999-10-01T00:00:00Z